Dr Grant Mair's new research testing a ‘clock tool’ for CT scans could open the door to life-changing treatments for stroke patients.
Published in the journal, The Lancet, the findings of the PISCES I study shed more light on the potential use of stem cell treatment for stroke.
Dr Shamim Quadir, Research Communications Manager at the Stroke Association comments.
Presented today at the European Stroke Organisation Conference in Gothenburg, the results of the international WAKE-UP trial suggest that thousands of people who wake up with a stroke each year in the UK could now benefit from life-changing thrombolysis treatment.
This research will investigate 2000 drugs that are already known to be safe for use in humans to see if they could help reduce the amount of damage to the brain which an intracerebral haemorrhage (a type of stroke caused by a bleed in the brain) causes.
PRESS RELEASE - Issued by University of Leicester Press Office on Tuesday 10 May
University of Leicester involved in the international ENCHANTED trial to improve survival rates of stroke victims. Stroke Association funds UK arm of the trial.
This study will show whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury. If successful, the study will pave the way for the design a larger definitive trial.
The project aims to employ similar techniques to the PLORAS project to predict which patients are most suited to which speech and language therapy.
The existing emergency medications that are used for stroke patients don’t always work, and not all stroke patients can receive them. This research is testing a new medication that could improve emergency treatment for stroke.
Comparing two treatment strategies in patients with visual problems after stroke